跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-DULOXETINE
Authorized
STANDARD
PRIVA-DULOXETINE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bdaa4114f435d5e0
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
bdaa4114f435d5e0
Drug Approval Canada Name
PRIVA-DULOXETINE
Product Name
PRIVA-DULOXETINE
Status
Cancelled Post Market
Status Date
2023-01-01
Original Market Date
2020-05-07
Din
02490420
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350002
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bdaa4114f435d5e0
Type
Standard
Back to Health Canada Approvals